Taken together, this evidence implied that targeting NF-κB and relevant cross-talk, including TLR4, SIRT1, and ERK1/2, might be the possible mechanism of CSF in relieving DM, DN, DR, diabetic cardiovascular diseases, and gestational diabetes. This evidence concerns the gene NFKB1 and diabetes mellitus.